Navigation Links
Glorious gadolinium gives flash memory a future
Date:8/24/2010

This release is also available in Chinese on EurekAlert! Chinese.

College Park, MD (August 24, 2010) -- Future flash memory could be faster and store more data without changing its basic design by using a clever nanocrystal material proposed by scientists at Taiwan's Chang Gung University, who describe a new logical element made with the rare earth material gadolinium in the journal APPLIED PHYSICS LETTERS, which is published by the American Institute of Physics.

It's well known in the semiconductor industry that conventional flash memory -- an essential element of mobile electronics today -- cannot improve much more because continued shrinking of its floating gate structure in the pursuit of faster performance and higher data storage capacity will soon degrade its ability to retain its memory. The situation has stimulated a wide range of research worldwide into dozens of alternative memory designs, but most attractive to industry would be one that requires the least modification to the existing floating-gate design.

A research group headed by Chao-Sung Lai at Chang Gung University in Taoyuan, Taiwan, has done just that. They have demonstrated that a cleverly modified floating gate made of gadolinium oxide -- an inexpensive rare-earth compound already used in other microelectronic applications -- has the write/erase speed and data retention properties that will enable smaller, faster and higher-capacity flash memories in the future.

"The low-voltage and low-power operation of this memory should make it especially attractive for future smartphones and other telecommunications applications," said Dr. Lai.

The Chang Gung researchers made two key insights that enabled their success. Last year, they realized that taken together, crystallized and
'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1 2

Related biology news :

1. Rare genetic disorder gives clues to autism, epilepsy, mental retardation
2. Dunn Foundation gives Rice $3M for collaborative research grants
3. Soybean grant gives researchers tools to unravel better bean
4. UBC researcher gives first-ever estimate of worldwide fish biomass and impact on climate change
5. Gardening gives older adults benefits like hand strength and self esteem
6. Gardening gives older adults benefits like hand strength and self-esteem
7. Worlds biggest snake gives climate clues
8. Safeway gives $685,000 to TGen for breast cancer research
9. Stem cell breakthrough gives new hope to sufferers of muscle-wasting diseases
10. M. D. Anderson gives first Margaret Kripke Legend Award to Margaret Foti
11. Cancer Genomics Browser gives cancer researchers a powerful new tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)... Dec. 9, 2014 CIE San Diego has ... provides the connective tissue that enhances care coordination among ... easily share client-level information; earned a second $1 million ... organizations serving seniors aging in community and; will be ... December 11 th 4-6p. CIE San ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a leading ... that its DigitalPersona ® Pro Enterprise software ... been deployed throughout First Bank branch locations in ... South Carolina and Virginia. First Bank, a ... Southern Pines, North Carolina , selected the ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... Scientists are reporting a new technique for mapping ... collected from the field and returned to a lab ... neither is readily available during a clean-up operation. The ... accurately predict the total amount of petroleum contaminants in ...
... bring forth the best properties of both ever since ... Age. In the latest successful merger, researchers at the ... of Maryland (UM) and the U.S. Food and Drug ... substances that individually have generated interest for their potential ...
... Cambridge, Md. (June 9, 2010) A team of scientists ... Point Laboratory will travel to the Gulf of Mexico later ... Horizon oil spill on plankton and fish communities in the ... Rapid Response Research (RAPID) grant for the expedition, which will ...
Cached Biology News:Predicting amount of oil in contaminated soils 2Liposome-hydrogel hybrids: No toil, no trouble for stronger bubbles 2
(Date:12/17/2014)... December 16, 2014 The Activated ... 2013, which is why IBISWorld updated its original industry ... to benefit from an intensified focus on environmental policy. ... new emission standards for power plants and a range ... to IBISWorld Industry Analyst Sarah Kahn, “a range of ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... 2014 Gene synthesis and bioengineering ... entered into a technology access and services agreement ... DNA2.0’s proprietary protein engineering technology, known as “ProteinGPS®” ... are extremely excited that the global leader ADM ... proprietary bioengineering technology has now been validated through ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
Breaking Biology Technology:Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... a Medicare Part D provider, with offices in New ... the company and ProCare, its former pharmacy benefit manager, ... ProCare based on Fox,s allegations of negligence and breach ... of Fox Insurance Company commented: "Fox Insurance is gratified ...
... Pharmaceuticals, Inc. announced today that data from ENGAGE ... novel, oral small molecule inhibitor of class I histone ... with relapsed or refractory Hodgkin,s lymphoma (HL).  This data ... 8:00 PM PT at the American Society of ...
... Life Technologies Corporation today announced that its Ion Personal ... Innovative New Product "MIP" Awards luncheon hosted by CONNECT in ... disruptive technology in the gene sequencing field. Since ... uptake in research labs around the world and has been ...
Cached Biology Technology:Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager 2Entinostat Demonstrates Activity in Hodgkin's Lymphoma 2Entinostat Demonstrates Activity in Hodgkin's Lymphoma 3Entinostat Demonstrates Activity in Hodgkin's Lymphoma 4Entinostat Demonstrates Activity in Hodgkin's Lymphoma 5Life Technologies' Ion Personal Genome Machine Receives San Diego's CONNECT Most Innovative New Product Award 2Life Technologies' Ion Personal Genome Machine Receives San Diego's CONNECT Most Innovative New Product Award 3